1. worldsfair
  2. The Speed of Money

The Speed of Money

By vlicata on August 30, 2010.

Wow! Either it's an odd coincidence, or the Latisse marketers are highly vigilant monetizers, because in less than 24 hours after I posted yesterday's rambling little piece about the eyelash wonder drug, a tasteful little ad for it showed up on the Scienceblogs homepage (cue spooky music now). Robot voice: "Oh yes, I will go buy Latisse now." I will try it on my cats, because I have always thought that cats with long eyelashes are wickedly beautiful.

But, Latisse, your ad says "ask your doctor about Latisse" -- I'm a bit disappointed. How could you pass up such a ripe possibility for pun-itization: i.e. "see your doctor about Latisse today".

Actually, ever since Warner music went in and hatcheted all of its songs out of youtube videos, I've believed that monetizing is the more rational business approach. Latisse, you are so lusciously poofy, and yet so business savvy too. Awesome.

PS: I'm guessing it almost certainly was SEED who initiated the monetizing, but the image of a bunch of people with great eyelashes vigilantly searching the web for mentions of Latisse is just so wonderful.

Tags
Knoxville '82: Where Miscellany Thrive
Beauty
eyelash
marketing
Money
pharmaceutical industry

More like this

Lashing out at Latisse®
I am running out of eyelash puns having written at least six posts since the summer of 2007 on a class of anti-glaucoma drugs that have been harnessed for their cosmetic side effect: promotion of eyelash growth. Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class…
Latisse!
The existence of the drug Latisse is clearly a harbinger of the end of modern civilization, in more ways than one, but it is also intensely fascinating and creepy. When I first heard of it, about a year ago, I really thought it was some sort of satirical article about the current status of big…
Latisse™: eyelashes are the new handbag
The tagline is from Elaine D'Farley at Self magazine talking about the FDA's then-pending approval of Allergan's Latisse™ for cosmetic growth of longer, thicker eyelashes treatment of hypotrichosis of the eyelashes. While not expected until early 2009, Jacob Goldstein at the WSJ Health Blog clued…
I don't quite get the same impression...
The New York Review of Books has a new article up about blogging, and although much of what Sarah Boxer says is familiar it seems that science blogs have a different sort of existence on the web than what's described in the piece. I'll keep my grumbling that the recently published Open Laboratory…